Experiment 1013921
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | NICHOLS,WC: MOERTEL,CG: RUBIN,J: SCHUTT,AJ: BRITELL,JC:. (1981). PHASE II TRIAL OF INDICINE N-OXIDE (INDI) IN PATIENTS WITH ADVANCED COLORECTAL CARCINOMA.. 65() |
| Amount utilized | |
| Compound isolated | |
| Disease | PHASE II CLINICAL TRIAL IN ADVANCED COLORECTAL CANCER(30 PATIEENTS). DAILY DOSING FOR 5 DAYS EVERY 5 WEEKS. NO OBJECTIVE RESPONSES IN THE 11 PATIENTS. NONHEMATOLOGIC TOXICITY WAS MILD. NO ALOPECIA OR STOMATITIS AND ALL DIARRHEA,CONSTIPATION AND ANOREXIA SEEMED TO BE RELATED TO THE CANCER HEMATOLOGIC TOXICITIES ARE DESCRIBED AND WERE THE MAJOR PROBLEM. RECOMMENDED NO FURTHER EVALUATION IN PATIENTS WITH ADVANCED COLORECTAL CANCER |
| Dose amount | 2.50 GM |
| Number | 3 |
| Qualitative result | INACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |